Wang W, Jiang TF, Han WZ, Jin L, Zhao XJ, Guo Y. Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia. World J Clin Cases 2020; 8(23): 5999-6008 [PMID: 33344598 DOI: 10.12998/wjcc.v8.i23.5999]
Corresponding Author of This Article
Ying Guo, MSN, RN, Chief Nurse, Department of Nursing, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Jinan 250021, Shandong Province, China. guoyingslyy@163.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Randomized Clinical Trial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Dec 6, 2020; 8(23): 5999-6008 Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5999
Table 1 Baseline characteristics of the patients included in each group
Group
Modified VM
Standard VM
χ2/t
P value
Patients (n)
180
181
Men [n (%)]
84 (46.7)
74 (40.88)
1.226
0.290
Age (yr)
51.76 ± 12.02
49.29 ± 13.59
1.823
0.069
Weight (kg)
64.89 ± 20.82
68.22 ± 13.27
-1.815
0.070
Duration of PSVT (yr)
7.27 ± 7.38
8.60 ± 8.10
-1.630
0.104
Systolic BP (mmHg)
127.42 ± 28.67
132.35 ± 19.46
-1.913
0.057
Diastolic BP (mmHg)
79.61 ± 18.17
82.77 ± 12.81
-1.912
0.057
Pulse (bpm)
75.71 ± 18.26
79.18 ± 15.22
-1.962
0.051
Serum potassium (mmol/L)
3.94 ± 0.89
4.08 ± 0.51
-1.826
0.069
Coronary heart disease [n (%)]
2 (1.11)
8 (4.42)
3.668
0.105
Hypertension [n (%)]
36 (2.00)
44 (24.31)
0.972
0.375
Diabetes [n (%)]
10 (5.56)
10 (5.52)
0.000
1.000
Pneumonia [n (%)]
2 (1.11)
0 (0.00)
2.022
0.155
Table 2 Comparison of success rate of paroxysmal supraventricular tachycardia conversion between the two groups (data are presented as number and percentage)
Group
n
Sinus rhythmafter multiple VM
Sinus rhythm after single VM
Modified VM
180
112 (62.22)
86 (47.78)
Standard VM
181
36 (19.89)
28 (15.47)
χ2 value
66.860
43.599
P value
< 0.001
< 0.001
Table 3 Comparison of the incidence of adverse events in both groups (data are presented as number and percentage)
Group
n
Chest tightness
Dizziness
Chest pain
Modified VM
180
10 (5.56)
6 (3.33)
4 (2.22)
Standard VM
181
8 (4.40)
4 (2.20)
2 (1.10)
χ2 value
0.246
0.423
0.689
P value
0.639
0.542
0.449
Table 4 Comparison of the cost-effective in both groups (data are presented as mean ± SD)
Group
n
Cost-effective (mean ± SD, yuan)
Modified VM
180
113.32 ± 45.22
Standard VM
181
140.91 ± 37.08
t value
-6.346
P value
0
Table 5 Comparison of the degree of patient acceptance in both groups
Group
n
Degree of acceptance (mean ± SD)
< 3 (%)
3’ (%)
> 3’ (%)
Modified VM
180
3.67 ± 0.69
6 (3.33)
58 (32.22)
116 (64.44)
Standard VM
181
3.54 ± 0.66
8 (4.42)
76 (41.99)
97 (53.59)
t/χ2 value
1.855
2.286
3.688
4.495
P value
0.064
0.786
0.064
0.042
Citation: Wang W, Jiang TF, Han WZ, Jin L, Zhao XJ, Guo Y. Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia. World J Clin Cases 2020; 8(23): 5999-6008